Unknown

Dataset Information

0

Axonal degeneration is blocked by nicotinamide mononucleotide adenylyltransferase (Nmnat) protein transduction into transected axons.


ABSTRACT: Axonal degeneration is an early and important component of many neurological disorders. Overexpression of nicotinamide mononucleotide adenylyltransferase (Nmnat), a component of the slow Wallerian degeneration (Wld(s)) protein, protects axons from a variety of insults. We found that transduction of Nmnat protein into severed axons via virus-like particles prevented axonal degeneration. The post-injury efficacy of Nmnat indicates that its protective effects occur locally within the axon and provides an opportunity to develop novel agents to treat axonal damage.

SUBMITTER: Sasaki Y 

PROVIDER: S-EPMC3009846 | biostudies-other | 2010 Dec

REPOSITORIES: biostudies-other

altmetric image

Publications

Axonal degeneration is blocked by nicotinamide mononucleotide adenylyltransferase (Nmnat) protein transduction into transected axons.

Sasaki Yo Y   Milbrandt Jeffrey J  

The Journal of biological chemistry 20101111 53


Axonal degeneration is an early and important component of many neurological disorders. Overexpression of nicotinamide mononucleotide adenylyltransferase (Nmnat), a component of the slow Wallerian degeneration (Wld(s)) protein, protects axons from a variety of insults. We found that transduction of Nmnat protein into severed axons via virus-like particles prevented axonal degeneration. The post-injury efficacy of Nmnat indicates that its protective effects occur locally within the axon and provi  ...[more]

Similar Datasets

| S-EPMC4601368 | biostudies-literature
| S-EPMC179734 | biostudies-literature
| S-EPMC4660618 | biostudies-literature
| S-EPMC3537136 | biostudies-literature
| S-EPMC5889475 | biostudies-literature
| S-EPMC3474723 | biostudies-literature